Drug Safety. hearings before the United States House Committee on Government Operations, Subcommittee on Intergovernmental Relations, Eighty-Ninth Congress, first session, on July 20, 22, 27, Aug. 3, 10, Sept. 24, 1965. Part 4 :

Continuation of hearing on controls over drugs that may be released for public consumption. Examines FDA role in monitoring pharmaceutical companies manufacturing practices. Focuses in part on case involving mixup of labels on a number of drugs produced by Abbott Laboratories of North Chicago, Ill.